New study to test Statin-Parkinson's link

Researchers are sufficiently worried by new study results that they are planning clinical trials involving thousands of people to examine the possible link between Parkinson's disease and statins, the world biggest selling drugs, reports Patrick Walter in Chemistry & Industry, the magazine of the SCI.

If you want to include this story in your blog, copy and paste this formatted text: